Roivant Sciences Ltd. (ROIV) Misses Q3 EPS by 7c

Roivant Sciences Ltd. (NASDAQ: ROIV) reported Q3 EPS of ($0.38), $0.07 worse than the analyst estimate of ($0.31). Revenue for the quarter came in at $1.99 million versus the consensus estimate of $5.13 million.

For earnings history and earnings-related data on Roivant Sciences Ltd. (ROIV) click here.

You May Also Be Interested In

• Reports Of Blasts Across Iran's Southern Regions: State TV - Bloomberg
• C3 AI (AI) call put ratio 1.6 calls to 1 put into quarter results
• Designer Brands (DBI) PT Lowered to $6 at UBS